Correspondence 0001213900-25-010052 from OS Therapies Inc (OSTX)
OS Therapies Inc
Date: Feb. 4, 2025 · CIK: 0001795091 · Accession: 0001213900-25-010052
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284631
Letter
EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 4, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Tim Buchmiller
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Thursday, February 6, 2025, or as soon as practicable thereafter.
Please advise the undersigned of the effectiveness of the Registration Statement.
Very truly yours,
/s/ Spencer G. Feldman
Show Raw Text
CORRESP
1
filename1.htm
EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 4, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Tim Buchmiller
Office of Life Sciences
Re:
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the “Company”),
we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on
Thursday, February 6, 2025, or as soon as practicable thereafter.
Please advise the undersigned
of the effectiveness of the Registration Statement.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc:
Paul A. Romness, MPH